Mayo, 2bPre­cise Join to De­velop Ge­nomics-Based CDS Tools

Health Data Management - - NEWSLINE - —Fred Baz­zoli

The Mayo Clinic will work with 2bPre­cise, a pre­ci­sion medicine com­pany, to de­velop and re­search a ge­nomics-based care pro­to­cols ap­proach to pro­vid­ing de­ci­sion sup­port at the point of care.

The well-known de­liv­ery sys­tem has signed a li­cense agree­ment with 2bPre­cise, a Pitts­burgh-based com­pany that of­fers an EHR-ag­nos­tic cloud-based pre­ci­sion medicine plat­form that har­mo­nizes ge­nomic data with re­search knowl­edge and clin­i­cal in­for­ma­tion.

The part­ners will use the 2bPre­cise plat­form and com­bine it with Mayo Clinic’s knowl­edge and elec­tronic phe­no­typ­ing al­go­rithms to fur­ther de­velop clin­i­cal pro­to­cols, which will be used to fur­ther de­velop the ca­pa­bil­i­ties of the plat­form.

Ini­tial work will be used to ap­ply re­search to mea­sure out­comes in pa­tients who have car­dio­vas­cu­lar ge­netic dis­ease.

The two or­ga­ni­za­tions will be­gin their col­lab­o­ra­tion by bring­ing a Mayo Clinic al­go­rithm for fa­mil­ial hy­per­c­holes­terolemia into the 2bPre­cise plat­form to de­rive in­sights from com­bined clin­i­cal and ge­nomic re­search data. The col­lab­o­ra­tion aims to aid clin­i­cal re­searchers with the abil­ity to test and val­i­date new pro­to­cols based on clin­i­cal-ge­nomic in­sights, with the ul­ti­mate goal of mak­ing these pro­to­cols avail­able for op­ti­mized de­ci­sion-mak­ing at the point of care.

The 2bPre­cise plat­form har­mo­nizes clin­i­cal and ge­nomic in­for­ma­tion to ex­tract pa­tient-spe­cific in­sights and present them in an ac­tion­able way to the clin­i­cian, within their cur­rent EHR work­flow, over­lay­ing knowl­edge sources to guide and en­able clin­i­cal ge­nomics at the point of care.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.